Business Context and Reporting Period
Company: Tharimmune, Inc. (Note: Metadata referenced "Canton Strategic Holdings, Inc.", but the filing text identifies the registrant as Tharimmune, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: August 26, 2025
Event: Entry into a Material Definitive Agreement for a registered direct offering.
Key Financial Metrics
This filing reports a capital raise event rather than operational financial results. Specific metrics include:
- Gross Proceeds: $5.35 million
- Securities Issued: 1,188,888 shares of Common Stock (or common stock equivalents)
- Offering Price: $4.50 per share
- Placement Fee: 10.0% of aggregate gross proceeds
- Expected Closing Date: August 27, 2025
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the execution of a securities purchase agreement to raise capital. This transaction will increase the company's cash position upon closing and result in the issuance of new shares, potentially diluting existing shareholders.
Guidance, Outlook, and Risks
Management Commentary: The Company engaged President Street Global, LLC and RF Lafferty & Co., Inc. as exclusive co-placement agents. The offering utilizes a previously effective Shelf Registration Statement (File No. 333-270684).
Contingencies: The closing of the Offering is subject to customary closing conditions.
Risks: The filing does not explicitly detail new risks beyond the standard dilution associated with equity offerings.
Investor Verification Checklist
- Verify the final closing date and confirmation of fund receipt (expected August 27, 2025).
- Confirm the exact number of shares issued versus common stock equivalents.
- Review the impact of the 10% placement fee on net proceeds.
- Check for any subsequent filings regarding the use of proceeds.